Ars Pharmaceuticals Inc SPRY
$9.85
▲ +1.77% 24H
About
Ars Pharmaceuticals Inc. specializes in the biopharmaceutical sector, focusing on the development of innovative, self-administered therapeutics aimed at improving patient outcomes. The company's primary purpose is to advance medical solutions for allergy-related indications, enhancing safety and convenience for patient…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees154
TickerSPRY
Statistics
Market Cap$978.1M
Revenue (TTM)$84.3M
Net Income-$171.3M
Net Margin-203.3%
EPS$-1.74
P/E168.25
P/S9.29
P/B8.05
EV/EBITDA-4.43
ROE-136.4%
Dividend Yield—
Price$9.85
Data: Twelve Data · Revenue = mcap / P/S